Nancy Kirsten

Title: Nancy Kirsten: Innovator in Vascular Treatment Technologies

Introduction

Nancy Kirsten is a prominent inventor based in San Carlos, CA (US). She has made significant contributions to the field of vascular medicine, particularly through her innovative drug-delivery systems. With a total of 2 patents, her work focuses on combining anti-proliferative and anti-inflammatory agents for the treatment of vascular disorders.

Latest Patents

Kirsten's latest patents include an "Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders - Drug-delivery systems." This patent describes drug-delivery stents that incorporate an anti-proliferative agent, such as everolimus, and an anti-inflammatory agent, such as clobetasol. The patent also outlines methods for treating vascular impairments like restenosis or vulnerable plaque. Another notable patent is the "Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device." This invention details a drug-delivery system that includes at least 100 µg of everolimus and clobetasol, with a specified ratio of everolimus to clobetasol. The system can be utilized in stents and provides methods for treating conditions such as restenosis.

Career Highlights

Nancy Kirsten is currently employed at Abbott Cardiovascular Systems, Inc., where she continues to develop innovative solutions for vascular health. Her work has been instrumental in advancing the field and improving patient outcomes.

Collaborations

Kirsten collaborates with notable colleagues, including Stephen R. Dugan and Gordon S. Stewart, who contribute to her research and development efforts.

Conclusion

Nancy Kirsten's contributions to vascular treatment technologies exemplify her dedication to innovation in medicine. Her patents reflect a commitment to improving patient care through advanced drug-delivery systems.